This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Carr, M. E. Articles by Todd, W. M. Search for Related Content PubMed PubMed Citation Articles by Carr, M. E., JR Articles by Todd, W. M. Social Bookmarking                         What's this?

Pain Relief and Clinical Improvement Temporally Related to the Use of Pentoxifylline in a Patient with Documented Cholesterol Emboli—A Case Report

Coagulation Special Studies Laboratory, Division of Hematology/Oncology and Rheumatology, Departments of Medicine and Pathology, Medical College of Virginia, McGuire V.A. Medical Center, Richmond, Virginia

Karen Sanders

Coagulation Special Studies Laboratory, Division of Hematology/Oncology and Rheumatology, Departments of Medicine and Pathology, Medical College of Virginia, McGuire V.A. Medical Center, Richmond, Virginia

William M. Todd

Coagulation Special Studies Laboratory, Division of Hematology/Oncology and Rheumatology, Departments of Medicine and Pathology, Medical College of Virginia, McGuire V.A. Medical Center, Richmond, Virginia

A sixty-six-year-old man with known severe atherosclerosis was admitted with painful feet and nonblanching purpuric lesions of his toes. He had under gone cardiac catheterization and coronary artery bypass five and three months, respectively, prior to admission. Initial treatment included: stopping the pa tient's lisinopril, increasing his nifedipine dose, and adding pentoxifylline 400 mg po tid. Within twenty-four hours pain was markedly decreased. Skin biopsy confirmed a diagnosis of cholesterol embolism. Pentoxifylline was stopped and intravenous heparin therapy was initiated. Within twenty-four hours, pain re turned. Nitrol paste applied to the top of each foot had no effect. After forty- eight hours, pentoxifylline was restarted. Once again, pain relief was noted within twenty-four hours, and after forty-eight hours both feet were visibly improved. Heparin and analgesics were discontinued. On the ninth hospital day, the patient was able to walk and was discharged to home. The innocuous nature of the intervention combined with the prompt nature of the therapeutic response support a short trial of pentoxifylline in patients with cholesterol em boli who are not responding to other therapy.

Angiology, Vol. 45, No. 1, 65-69 (1994)
DOI: 10.1177/000331979404500110


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?